nodes	percent_of_prediction	percent_of_DWPC	metapath
Bismuth Subsalicylate—PTGS1—breast cancer	0.292	0.481	CbGaD
Bismuth Subsalicylate—PTGS2—breast cancer	0.167	0.275	CbGaD
Bismuth Subsalicylate—ALB—breast cancer	0.149	0.245	CbGaD
Bismuth Subsalicylate—TF—embryo—breast cancer	0.00317	0.0758	CbGeAlD
Bismuth Subsalicylate—TF—epithelium—breast cancer	0.00259	0.0618	CbGeAlD
Bismuth Subsalicylate—TF—skin of body—breast cancer	0.00246	0.0588	CbGeAlD
Bismuth Subsalicylate—ALB—mammary gland—breast cancer	0.00242	0.0578	CbGeAlD
Bismuth Subsalicylate—TF—uterus—breast cancer	0.00214	0.0511	CbGeAlD
Bismuth Subsalicylate—TF—adipose tissue—breast cancer	0.00209	0.05	CbGeAlD
Bismuth Subsalicylate—TF—female reproductive system—breast cancer	0.00192	0.0459	CbGeAlD
Bismuth Subsalicylate—TF—adrenal gland—breast cancer	0.00188	0.0448	CbGeAlD
Bismuth Subsalicylate—TF—bone marrow—breast cancer	0.00182	0.0434	CbGeAlD
Bismuth Subsalicylate—TF—female gonad—breast cancer	0.00175	0.0418	CbGeAlD
Bismuth Subsalicylate—TF—endocrine gland—breast cancer	0.00163	0.0389	CbGeAlD
Bismuth Subsalicylate—ALB—Irinotecan—breast cancer	0.00162	0.402	CbGbCtD
Bismuth Subsalicylate—ALB—Fluorouracil—breast cancer	0.00155	0.386	CbGbCtD
Bismuth Subsalicylate—PTGS1—nipple—breast cancer	0.00114	0.0272	CbGeAlD
Bismuth Subsalicylate—TF—lymph node—breast cancer	0.00113	0.0269	CbGeAlD
Bismuth Subsalicylate—ALB—adrenal gland—breast cancer	0.000976	0.0233	CbGeAlD
Bismuth Subsalicylate—PTGS2—embryo—breast cancer	0.000899	0.0215	CbGeAlD
Bismuth Subsalicylate—ALB—Methotrexate—breast cancer	0.000855	0.213	CbGbCtD
Bismuth Subsalicylate—PTGS1—epithelium—breast cancer	0.000768	0.0183	CbGeAlD
Bismuth Subsalicylate—PTGS2—epithelium—breast cancer	0.000734	0.0175	CbGeAlD
Bismuth Subsalicylate—PTGS1—skin of body—breast cancer	0.00073	0.0174	CbGeAlD
Bismuth Subsalicylate—PTGS2—skin of body—breast cancer	0.000698	0.0167	CbGeAlD
Bismuth Subsalicylate—PTGS1—endometrium—breast cancer	0.000688	0.0164	CbGeAlD
Bismuth Subsalicylate—PTGS2—endometrium—breast cancer	0.000658	0.0157	CbGeAlD
Bismuth Subsalicylate—PTGS1—uterus—breast cancer	0.000634	0.0151	CbGeAlD
Bismuth Subsalicylate—PTGS1—pituitary gland—breast cancer	0.000623	0.0149	CbGeAlD
Bismuth Subsalicylate—PTGS1—adipose tissue—breast cancer	0.00062	0.0148	CbGeAlD
Bismuth Subsalicylate—PTGS2—uterus—breast cancer	0.000606	0.0145	CbGeAlD
Bismuth Subsalicylate—PTGS2—pituitary gland—breast cancer	0.000595	0.0142	CbGeAlD
Bismuth Subsalicylate—PTGS2—adipose tissue—breast cancer	0.000593	0.0142	CbGeAlD
Bismuth Subsalicylate—ALB—lymph node—breast cancer	0.000585	0.014	CbGeAlD
Bismuth Subsalicylate—PTGS1—female reproductive system—breast cancer	0.00057	0.0136	CbGeAlD
Bismuth Subsalicylate—PTGS1—adrenal gland—breast cancer	0.000556	0.0133	CbGeAlD
Bismuth Subsalicylate—PTGS2—female reproductive system—breast cancer	0.000545	0.013	CbGeAlD
Bismuth Subsalicylate—PTGS2—adrenal gland—breast cancer	0.000532	0.0127	CbGeAlD
Bismuth Subsalicylate—PTGS1—female gonad—breast cancer	0.000519	0.0124	CbGeAlD
Bismuth Subsalicylate—PTGS2—bone marrow—breast cancer	0.000515	0.0123	CbGeAlD
Bismuth Subsalicylate—PTGS2—female gonad—breast cancer	0.000496	0.0118	CbGeAlD
Bismuth Subsalicylate—PTGS1—endocrine gland—breast cancer	0.000483	0.0115	CbGeAlD
Bismuth Subsalicylate—PTGS2—endocrine gland—breast cancer	0.000461	0.011	CbGeAlD
Bismuth Subsalicylate—PTGS1—lymph node—breast cancer	0.000334	0.00797	CbGeAlD
Bismuth Subsalicylate—PTGS2—lymph node—breast cancer	0.000319	0.00762	CbGeAlD
Bismuth Subsalicylate—Dizziness—Tamoxifen—breast cancer	0.000174	0.000899	CcSEcCtD
Bismuth Subsalicylate—Anorexia—Gemcitabine—breast cancer	0.000173	0.000891	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Vinblastine—breast cancer	0.000173	0.00089	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Goserelin—breast cancer	0.000172	0.000889	CcSEcCtD
Bismuth Subsalicylate—Erythema multiforme—Docetaxel—breast cancer	0.000171	0.000883	CcSEcCtD
Bismuth Subsalicylate—Urticaria—Thiotepa—breast cancer	0.000171	0.000883	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Thiotepa—breast cancer	0.00017	0.000878	CcSEcCtD
Bismuth Subsalicylate—Headache—Vinblastine—breast cancer	0.00017	0.000877	CcSEcCtD
Bismuth Subsalicylate—Anorexia—Fluorouracil—breast cancer	0.00017	0.000876	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Tamoxifen—breast cancer	0.000168	0.000865	CcSEcCtD
Bismuth Subsalicylate—Lethargy—Doxorubicin—breast cancer	0.000167	0.000859	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Goserelin—breast cancer	0.000167	0.000859	CcSEcCtD
Bismuth Subsalicylate—Rash—Tamoxifen—breast cancer	0.000166	0.000857	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Tamoxifen—breast cancer	0.000166	0.000857	CcSEcCtD
Bismuth Subsalicylate—Erythema multiforme—Capecitabine—breast cancer	0.000166	0.000855	CcSEcCtD
Bismuth Subsalicylate—Somnolence—Mitoxantrone—breast cancer	0.000165	0.000853	CcSEcCtD
Bismuth Subsalicylate—Somnolence—Irinotecan—breast cancer	0.000165	0.000853	CcSEcCtD
Bismuth Subsalicylate—Headache—Tamoxifen—breast cancer	0.000165	0.000852	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Melphalan—breast cancer	0.000164	0.000847	CcSEcCtD
Bismuth Subsalicylate—Hyponatraemia—Doxorubicin—breast cancer	0.000164	0.000846	CcSEcCtD
Bismuth Subsalicylate—Dyspepsia—Irinotecan—breast cancer	0.000164	0.000845	CcSEcCtD
Bismuth Subsalicylate—Dyspepsia—Mitoxantrone—breast cancer	0.000164	0.000845	CcSEcCtD
Bismuth Subsalicylate—Tinnitus—Capecitabine—breast cancer	0.000163	0.000843	CcSEcCtD
Bismuth Subsalicylate—Asthma—Methotrexate—breast cancer	0.000163	0.000841	CcSEcCtD
Bismuth Subsalicylate—Rash—Melphalan—breast cancer	0.000163	0.00084	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Melphalan—breast cancer	0.000163	0.000839	CcSEcCtD
Bismuth Subsalicylate—Decreased appetite—Mitoxantrone—breast cancer	0.000162	0.000834	CcSEcCtD
Bismuth Subsalicylate—Decreased appetite—Irinotecan—breast cancer	0.000162	0.000834	CcSEcCtD
Bismuth Subsalicylate—Nausea—Vinblastine—breast cancer	0.000161	0.000831	CcSEcCtD
Bismuth Subsalicylate—Abdominal pain upper—Epirubicin—breast cancer	0.000161	0.000831	CcSEcCtD
Bismuth Subsalicylate—Somnolence—Gemcitabine—breast cancer	0.000161	0.000831	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Goserelin—breast cancer	0.00016	0.000826	CcSEcCtD
Bismuth Subsalicylate—Pruritus—Vinorelbine—breast cancer	0.00016	0.000823	CcSEcCtD
Bismuth Subsalicylate—Constipation—Mitoxantrone—breast cancer	0.000159	0.00082	CcSEcCtD
Bismuth Subsalicylate—Pain—Irinotecan—breast cancer	0.000159	0.00082	CcSEcCtD
Bismuth Subsalicylate—Pain—Mitoxantrone—breast cancer	0.000159	0.00082	CcSEcCtD
Bismuth Subsalicylate—Constipation—Irinotecan—breast cancer	0.000159	0.00082	CcSEcCtD
Bismuth Subsalicylate—Rash—Goserelin—breast cancer	0.000159	0.000819	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Goserelin—breast cancer	0.000159	0.000818	CcSEcCtD
Bismuth Subsalicylate—Somnolence—Fluorouracil—breast cancer	0.000158	0.000817	CcSEcCtD
Bismuth Subsalicylate—Headache—Goserelin—breast cancer	0.000158	0.000814	CcSEcCtD
Bismuth Subsalicylate—Erythema—Docetaxel—breast cancer	0.000158	0.000813	CcSEcCtD
Bismuth Subsalicylate—Decreased appetite—Gemcitabine—breast cancer	0.000158	0.000812	CcSEcCtD
Bismuth Subsalicylate—Dyspepsia—Fluorouracil—breast cancer	0.000157	0.000809	CcSEcCtD
Bismuth Subsalicylate—Nausea—Tamoxifen—breast cancer	0.000157	0.000808	CcSEcCtD
Bismuth Subsalicylate—Abdominal discomfort—Methotrexate—breast cancer	0.000156	0.000806	CcSEcCtD
Bismuth Subsalicylate—Constipation—Gemcitabine—breast cancer	0.000155	0.000799	CcSEcCtD
Bismuth Subsalicylate—Pain—Gemcitabine—breast cancer	0.000155	0.000799	CcSEcCtD
Bismuth Subsalicylate—Decreased appetite—Fluorouracil—breast cancer	0.000155	0.000799	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Vinorelbine—breast cancer	0.000154	0.000796	CcSEcCtD
Bismuth Subsalicylate—Dysgeusia—Docetaxel—breast cancer	0.000154	0.000796	CcSEcCtD
Bismuth Subsalicylate—Nausea—Melphalan—breast cancer	0.000153	0.000791	CcSEcCtD
Bismuth Subsalicylate—Feeling abnormal—Mitoxantrone—breast cancer	0.000153	0.000791	CcSEcCtD
Bismuth Subsalicylate—Feeling abnormal—Irinotecan—breast cancer	0.000153	0.000791	CcSEcCtD
Bismuth Subsalicylate—Confusional state—Paclitaxel—breast cancer	0.000153	0.000789	CcSEcCtD
Bismuth Subsalicylate—Erythema—Capecitabine—breast cancer	0.000153	0.000787	CcSEcCtD
Bismuth Subsalicylate—Asthma—Epirubicin—breast cancer	0.000153	0.000787	CcSEcCtD
Bismuth Subsalicylate—Pruritus—Thiotepa—breast cancer	0.000152	0.000786	CcSEcCtD
Bismuth Subsalicylate—Pain—Fluorouracil—breast cancer	0.000152	0.000786	CcSEcCtD
Bismuth Subsalicylate—Oedema—Paclitaxel—breast cancer	0.000152	0.000782	CcSEcCtD
Bismuth Subsalicylate—Infection—Paclitaxel—breast cancer	0.000151	0.000777	CcSEcCtD
Bismuth Subsalicylate—Nausea—Goserelin—breast cancer	0.00015	0.000771	CcSEcCtD
Bismuth Subsalicylate—Dysgeusia—Capecitabine—breast cancer	0.000149	0.00077	CcSEcCtD
Bismuth Subsalicylate—Feeling abnormal—Gemcitabine—breast cancer	0.000149	0.00077	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Vinorelbine—breast cancer	0.000149	0.000769	CcSEcCtD
Bismuth Subsalicylate—Abdominal pain upper—Doxorubicin—breast cancer	0.000149	0.000769	CcSEcCtD
Bismuth Subsalicylate—Urticaria—Mitoxantrone—breast cancer	0.000148	0.000762	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Thiotepa—breast cancer	0.000147	0.00076	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Mitoxantrone—breast cancer	0.000147	0.000758	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Irinotecan—breast cancer	0.000147	0.000758	CcSEcCtD
Bismuth Subsalicylate—Feeling abnormal—Fluorouracil—breast cancer	0.000147	0.000757	CcSEcCtD
Bismuth Subsalicylate—Drowsiness—Methotrexate—breast cancer	0.000145	0.000749	CcSEcCtD
Bismuth Subsalicylate—Anorexia—Paclitaxel—breast cancer	0.000145	0.000746	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Vinorelbine—breast cancer	0.000143	0.00074	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Gemcitabine—breast cancer	0.000143	0.000739	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Thiotepa—breast cancer	0.000142	0.000735	CcSEcCtD
Bismuth Subsalicylate—Rash—Vinorelbine—breast cancer	0.000142	0.000733	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Vinorelbine—breast cancer	0.000142	0.000733	CcSEcCtD
Bismuth Subsalicylate—Urticaria—Fluorouracil—breast cancer	0.000142	0.00073	CcSEcCtD
Bismuth Subsalicylate—Headache—Vinorelbine—breast cancer	0.000141	0.000729	CcSEcCtD
Bismuth Subsalicylate—Asthma—Doxorubicin—breast cancer	0.000141	0.000728	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Fluorouracil—breast cancer	0.000141	0.000726	CcSEcCtD
Bismuth Subsalicylate—Weight increased—Epirubicin—breast cancer	0.000139	0.000716	CcSEcCtD
Bismuth Subsalicylate—Epistaxis—Methotrexate—breast cancer	0.000137	0.000707	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Thiotepa—breast cancer	0.000137	0.000706	CcSEcCtD
Bismuth Subsalicylate—Drowsiness—Epirubicin—breast cancer	0.000136	0.000701	CcSEcCtD
Bismuth Subsalicylate—Rash—Thiotepa—breast cancer	0.000136	0.0007	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Thiotepa—breast cancer	0.000136	0.0007	CcSEcCtD
Bismuth Subsalicylate—Headache—Thiotepa—breast cancer	0.000135	0.000696	CcSEcCtD
Bismuth Subsalicylate—Somnolence—Paclitaxel—breast cancer	0.000135	0.000696	CcSEcCtD
Bismuth Subsalicylate—Nausea—Vinorelbine—breast cancer	0.000134	0.000691	CcSEcCtD
Bismuth Subsalicylate—Dyspepsia—Paclitaxel—breast cancer	0.000134	0.000689	CcSEcCtD
Bismuth Subsalicylate—Decreased appetite—Paclitaxel—breast cancer	0.000132	0.00068	CcSEcCtD
Bismuth Subsalicylate—Hepatitis—Methotrexate—breast cancer	0.00013	0.000673	CcSEcCtD
Bismuth Subsalicylate—Pain—Paclitaxel—breast cancer	0.00013	0.000669	CcSEcCtD
Bismuth Subsalicylate—Constipation—Paclitaxel—breast cancer	0.00013	0.000669	CcSEcCtD
Bismuth Subsalicylate—Confusional state—Docetaxel—breast cancer	0.00013	0.000669	CcSEcCtD
Bismuth Subsalicylate—Oedema—Docetaxel—breast cancer	0.000129	0.000663	CcSEcCtD
Bismuth Subsalicylate—Weight increased—Doxorubicin—breast cancer	0.000128	0.000662	CcSEcCtD
Bismuth Subsalicylate—Epistaxis—Epirubicin—breast cancer	0.000128	0.000662	CcSEcCtD
Bismuth Subsalicylate—Pruritus—Gemcitabine—breast cancer	0.000128	0.000661	CcSEcCtD
Bismuth Subsalicylate—Nausea—Thiotepa—breast cancer	0.000128	0.00066	CcSEcCtD
Bismuth Subsalicylate—Infection—Docetaxel—breast cancer	0.000128	0.000659	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Irinotecan—breast cancer	0.000127	0.000656	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Mitoxantrone—breast cancer	0.000127	0.000656	CcSEcCtD
Bismuth Subsalicylate—Pruritus—Fluorouracil—breast cancer	0.000126	0.00065	CcSEcCtD
Bismuth Subsalicylate—Drowsiness—Doxorubicin—breast cancer	0.000126	0.000649	CcSEcCtD
Bismuth Subsalicylate—Confusional state—Capecitabine—breast cancer	0.000126	0.000647	CcSEcCtD
Bismuth Subsalicylate—Feeling abnormal—Paclitaxel—breast cancer	0.000125	0.000645	CcSEcCtD
Bismuth Subsalicylate—Oedema—Capecitabine—breast cancer	0.000125	0.000642	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Gemcitabine—breast cancer	0.000124	0.000639	CcSEcCtD
Bismuth Subsalicylate—Infection—Capecitabine—breast cancer	0.000124	0.000638	CcSEcCtD
Bismuth Subsalicylate—Erythema multiforme—Methotrexate—breast cancer	0.000123	0.000636	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Irinotecan—breast cancer	0.000123	0.000634	CcSEcCtD
Bismuth Subsalicylate—Anorexia—Docetaxel—breast cancer	0.000123	0.000632	CcSEcCtD
Bismuth Subsalicylate—Hepatitis—Epirubicin—breast cancer	0.000122	0.00063	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Fluorouracil—breast cancer	0.000122	0.000629	CcSEcCtD
Bismuth Subsalicylate—Tinnitus—Methotrexate—breast cancer	0.000122	0.000627	CcSEcCtD
Bismuth Subsalicylate—Urticaria—Paclitaxel—breast cancer	0.000121	0.000622	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Paclitaxel—breast cancer	0.00012	0.000619	CcSEcCtD
Bismuth Subsalicylate—Epistaxis—Doxorubicin—breast cancer	0.000119	0.000612	CcSEcCtD
Bismuth Subsalicylate—Anorexia—Capecitabine—breast cancer	0.000119	0.000612	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Irinotecan—breast cancer	0.000118	0.00061	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Mitoxantrone—breast cancer	0.000118	0.00061	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Fluorouracil—breast cancer	0.000118	0.000608	CcSEcCtD
Bismuth Subsalicylate—Rash—Irinotecan—breast cancer	0.000117	0.000605	CcSEcCtD
Bismuth Subsalicylate—Rash—Mitoxantrone—breast cancer	0.000117	0.000605	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Irinotecan—breast cancer	0.000117	0.000604	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Mitoxantrone—breast cancer	0.000117	0.000604	CcSEcCtD
Bismuth Subsalicylate—Headache—Irinotecan—breast cancer	0.000117	0.000601	CcSEcCtD
Bismuth Subsalicylate—Headache—Mitoxantrone—breast cancer	0.000117	0.000601	CcSEcCtD
Bismuth Subsalicylate—Erythema multiforme—Epirubicin—breast cancer	0.000115	0.000595	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Gemcitabine—breast cancer	0.000115	0.000594	CcSEcCtD
Bismuth Subsalicylate—Somnolence—Docetaxel—breast cancer	0.000114	0.00059	CcSEcCtD
Bismuth Subsalicylate—Rash—Gemcitabine—breast cancer	0.000114	0.000589	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Gemcitabine—breast cancer	0.000114	0.000589	CcSEcCtD
Bismuth Subsalicylate—Tinnitus—Epirubicin—breast cancer	0.000114	0.000587	CcSEcCtD
Bismuth Subsalicylate—Erythema—Methotrexate—breast cancer	0.000114	0.000586	CcSEcCtD
Bismuth Subsalicylate—Headache—Gemcitabine—breast cancer	0.000114	0.000585	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Fluorouracil—breast cancer	0.000113	0.000584	CcSEcCtD
Bismuth Subsalicylate—Dyspepsia—Docetaxel—breast cancer	0.000113	0.000584	CcSEcCtD
Bismuth Subsalicylate—Hepatitis—Doxorubicin—breast cancer	0.000113	0.000583	CcSEcCtD
Bismuth Subsalicylate—Rash—Fluorouracil—breast cancer	0.000112	0.000579	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Fluorouracil—breast cancer	0.000112	0.000579	CcSEcCtD
Bismuth Subsalicylate—Decreased appetite—Docetaxel—breast cancer	0.000112	0.000577	CcSEcCtD
Bismuth Subsalicylate—Headache—Fluorouracil—breast cancer	0.000112	0.000576	CcSEcCtD
Bismuth Subsalicylate—Dysgeusia—Methotrexate—breast cancer	0.000111	0.000574	CcSEcCtD
Bismuth Subsalicylate—Nausea—Irinotecan—breast cancer	0.000111	0.00057	CcSEcCtD
Bismuth Subsalicylate—Nausea—Mitoxantrone—breast cancer	0.000111	0.00057	CcSEcCtD
Bismuth Subsalicylate—Pain—Docetaxel—breast cancer	0.00011	0.000567	CcSEcCtD
Bismuth Subsalicylate—Constipation—Docetaxel—breast cancer	0.00011	0.000567	CcSEcCtD
Bismuth Subsalicylate—Dyspepsia—Capecitabine—breast cancer	0.00011	0.000565	CcSEcCtD
Bismuth Subsalicylate—Decreased appetite—Capecitabine—breast cancer	0.000108	0.000558	CcSEcCtD
Bismuth Subsalicylate—Nausea—Gemcitabine—breast cancer	0.000108	0.000555	CcSEcCtD
Bismuth Subsalicylate—Pruritus—Paclitaxel—breast cancer	0.000107	0.000554	CcSEcCtD
Bismuth Subsalicylate—Erythema multiforme—Doxorubicin—breast cancer	0.000107	0.000551	CcSEcCtD
Bismuth Subsalicylate—Pain—Capecitabine—breast cancer	0.000106	0.000549	CcSEcCtD
Bismuth Subsalicylate—Constipation—Capecitabine—breast cancer	0.000106	0.000549	CcSEcCtD
Bismuth Subsalicylate—Erythema—Epirubicin—breast cancer	0.000106	0.000548	CcSEcCtD
Bismuth Subsalicylate—Feeling abnormal—Docetaxel—breast cancer	0.000106	0.000547	CcSEcCtD
Bismuth Subsalicylate—Nausea—Fluorouracil—breast cancer	0.000106	0.000546	CcSEcCtD
Bismuth Subsalicylate—Tinnitus—Doxorubicin—breast cancer	0.000105	0.000543	CcSEcCtD
Bismuth Subsalicylate—Dysgeusia—Epirubicin—breast cancer	0.000104	0.000537	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Paclitaxel—breast cancer	0.000104	0.000535	CcSEcCtD
Bismuth Subsalicylate—Feeling abnormal—Capecitabine—breast cancer	0.000103	0.000529	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Docetaxel—breast cancer	0.000102	0.000524	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Paclitaxel—breast cancer	0.0001	0.000517	CcSEcCtD
Bismuth Subsalicylate—Urticaria—Capecitabine—breast cancer	9.89e-05	0.00051	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Capecitabine—breast cancer	9.84e-05	0.000508	CcSEcCtD
Bismuth Subsalicylate—Erythema—Doxorubicin—breast cancer	9.84e-05	0.000507	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Paclitaxel—breast cancer	9.65e-05	0.000497	CcSEcCtD
Bismuth Subsalicylate—Dysgeusia—Doxorubicin—breast cancer	9.63e-05	0.000497	CcSEcCtD
Bismuth Subsalicylate—Rash—Paclitaxel—breast cancer	9.57e-05	0.000493	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Paclitaxel—breast cancer	9.56e-05	0.000493	CcSEcCtD
Bismuth Subsalicylate—Headache—Paclitaxel—breast cancer	9.51e-05	0.00049	CcSEcCtD
Bismuth Subsalicylate—Confusional state—Methotrexate—breast cancer	9.35e-05	0.000482	CcSEcCtD
Bismuth Subsalicylate—Infection—Methotrexate—breast cancer	9.21e-05	0.000475	CcSEcCtD
Bismuth Subsalicylate—Pruritus—Docetaxel—breast cancer	9.1e-05	0.000469	CcSEcCtD
Bismuth Subsalicylate—Nausea—Paclitaxel—breast cancer	9.01e-05	0.000465	CcSEcCtD
Bismuth Subsalicylate—Anorexia—Methotrexate—breast cancer	8.84e-05	0.000456	CcSEcCtD
Bismuth Subsalicylate—Pruritus—Capecitabine—breast cancer	8.81e-05	0.000454	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Docetaxel—breast cancer	8.8e-05	0.000454	CcSEcCtD
Bismuth Subsalicylate—Confusional state—Epirubicin—breast cancer	8.75e-05	0.000451	CcSEcCtD
Bismuth Subsalicylate—Oedema—Epirubicin—breast cancer	8.68e-05	0.000447	CcSEcCtD
Bismuth Subsalicylate—Infection—Epirubicin—breast cancer	8.62e-05	0.000444	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Capecitabine—breast cancer	8.52e-05	0.000439	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Docetaxel—breast cancer	8.51e-05	0.000439	CcSEcCtD
Bismuth Subsalicylate—Anorexia—Epirubicin—breast cancer	8.27e-05	0.000426	CcSEcCtD
Bismuth Subsalicylate—Somnolence—Methotrexate—breast cancer	8.24e-05	0.000425	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Capecitabine—breast cancer	8.23e-05	0.000425	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Docetaxel—breast cancer	8.18e-05	0.000422	CcSEcCtD
Bismuth Subsalicylate—Dyspepsia—Methotrexate—breast cancer	8.16e-05	0.000421	CcSEcCtD
Bismuth Subsalicylate—Rash—Docetaxel—breast cancer	8.11e-05	0.000418	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Docetaxel—breast cancer	8.1e-05	0.000418	CcSEcCtD
Bismuth Subsalicylate—Confusional state—Doxorubicin—breast cancer	8.09e-05	0.000417	CcSEcCtD
Bismuth Subsalicylate—Decreased appetite—Methotrexate—breast cancer	8.06e-05	0.000416	CcSEcCtD
Bismuth Subsalicylate—Headache—Docetaxel—breast cancer	8.06e-05	0.000415	CcSEcCtD
Bismuth Subsalicylate—Oedema—Doxorubicin—breast cancer	8.03e-05	0.000414	CcSEcCtD
Bismuth Subsalicylate—Infection—Doxorubicin—breast cancer	7.97e-05	0.000411	CcSEcCtD
Bismuth Subsalicylate—Pain—Methotrexate—breast cancer	7.93e-05	0.000409	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Capecitabine—breast cancer	7.92e-05	0.000408	CcSEcCtD
Bismuth Subsalicylate—Rash—Capecitabine—breast cancer	7.85e-05	0.000405	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Capecitabine—breast cancer	7.84e-05	0.000404	CcSEcCtD
Bismuth Subsalicylate—Headache—Capecitabine—breast cancer	7.8e-05	0.000402	CcSEcCtD
Bismuth Subsalicylate—Somnolence—Epirubicin—breast cancer	7.71e-05	0.000398	CcSEcCtD
Bismuth Subsalicylate—Anorexia—Doxorubicin—breast cancer	7.65e-05	0.000395	CcSEcCtD
Bismuth Subsalicylate—Nausea—Docetaxel—breast cancer	7.64e-05	0.000394	CcSEcCtD
Bismuth Subsalicylate—Feeling abnormal—Methotrexate—breast cancer	7.64e-05	0.000394	CcSEcCtD
Bismuth Subsalicylate—Dyspepsia—Epirubicin—breast cancer	7.64e-05	0.000394	CcSEcCtD
Bismuth Subsalicylate—Decreased appetite—Epirubicin—breast cancer	7.54e-05	0.000389	CcSEcCtD
Bismuth Subsalicylate—Pain—Epirubicin—breast cancer	7.42e-05	0.000383	CcSEcCtD
Bismuth Subsalicylate—Constipation—Epirubicin—breast cancer	7.42e-05	0.000383	CcSEcCtD
Bismuth Subsalicylate—Nausea—Capecitabine—breast cancer	7.4e-05	0.000381	CcSEcCtD
Bismuth Subsalicylate—Urticaria—Methotrexate—breast cancer	7.36e-05	0.00038	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Methotrexate—breast cancer	7.33e-05	0.000378	CcSEcCtD
Bismuth Subsalicylate—Feeling abnormal—Epirubicin—breast cancer	7.15e-05	0.000369	CcSEcCtD
Bismuth Subsalicylate—Somnolence—Doxorubicin—breast cancer	7.14e-05	0.000368	CcSEcCtD
Bismuth Subsalicylate—Dyspepsia—Doxorubicin—breast cancer	7.07e-05	0.000364	CcSEcCtD
Bismuth Subsalicylate—Decreased appetite—Doxorubicin—breast cancer	6.98e-05	0.00036	CcSEcCtD
Bismuth Subsalicylate—Urticaria—Epirubicin—breast cancer	6.89e-05	0.000355	CcSEcCtD
Bismuth Subsalicylate—Constipation—Doxorubicin—breast cancer	6.86e-05	0.000354	CcSEcCtD
Bismuth Subsalicylate—Pain—Doxorubicin—breast cancer	6.86e-05	0.000354	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Epirubicin—breast cancer	6.86e-05	0.000354	CcSEcCtD
Bismuth Subsalicylate—Feeling abnormal—Doxorubicin—breast cancer	6.61e-05	0.000341	CcSEcCtD
Bismuth Subsalicylate—Pruritus—Methotrexate—breast cancer	6.56e-05	0.000338	CcSEcCtD
Bismuth Subsalicylate—Urticaria—Doxorubicin—breast cancer	6.38e-05	0.000329	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Doxorubicin—breast cancer	6.35e-05	0.000327	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Methotrexate—breast cancer	6.34e-05	0.000327	CcSEcCtD
Bismuth Subsalicylate—Pruritus—Epirubicin—breast cancer	6.14e-05	0.000316	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Methotrexate—breast cancer	6.13e-05	0.000316	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Epirubicin—breast cancer	5.94e-05	0.000306	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Methotrexate—breast cancer	5.89e-05	0.000304	CcSEcCtD
Bismuth Subsalicylate—Rash—Methotrexate—breast cancer	5.84e-05	0.000301	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Methotrexate—breast cancer	5.84e-05	0.000301	CcSEcCtD
Bismuth Subsalicylate—Headache—Methotrexate—breast cancer	5.81e-05	0.000299	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Epirubicin—breast cancer	5.74e-05	0.000296	CcSEcCtD
Bismuth Subsalicylate—Pruritus—Doxorubicin—breast cancer	5.68e-05	0.000293	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Epirubicin—breast cancer	5.52e-05	0.000284	CcSEcCtD
Bismuth Subsalicylate—Nausea—Methotrexate—breast cancer	5.51e-05	0.000284	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Doxorubicin—breast cancer	5.49e-05	0.000283	CcSEcCtD
Bismuth Subsalicylate—Rash—Epirubicin—breast cancer	5.47e-05	0.000282	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Epirubicin—breast cancer	5.46e-05	0.000282	CcSEcCtD
Bismuth Subsalicylate—Headache—Epirubicin—breast cancer	5.43e-05	0.00028	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Doxorubicin—breast cancer	5.31e-05	0.000274	CcSEcCtD
Bismuth Subsalicylate—Nausea—Epirubicin—breast cancer	5.15e-05	0.000266	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Doxorubicin—breast cancer	5.1e-05	0.000263	CcSEcCtD
Bismuth Subsalicylate—Rash—Doxorubicin—breast cancer	5.06e-05	0.000261	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Doxorubicin—breast cancer	5.06e-05	0.000261	CcSEcCtD
Bismuth Subsalicylate—Headache—Doxorubicin—breast cancer	5.03e-05	0.000259	CcSEcCtD
Bismuth Subsalicylate—Nausea—Doxorubicin—breast cancer	4.77e-05	0.000246	CcSEcCtD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—CYP1A1—breast cancer	1.45e-05	9.55e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet activation, signaling and aggregation—VEGFA—breast cancer	1.45e-05	9.53e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—GPX2—breast cancer	1.45e-05	9.52e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—GSTA2—breast cancer	1.45e-05	9.52e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—SLC5A5—breast cancer	1.43e-05	9.43e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—NCOA3—breast cancer	1.43e-05	9.41e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—MMP1—breast cancer	1.43e-05	9.41e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—GPX4—breast cancer	1.43e-05	9.4e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—SULT1A1—breast cancer	1.43e-05	9.4e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—SLC2A2—breast cancer	1.42e-05	9.34e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	1.4e-05	9.24e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—CDK2—breast cancer	1.4e-05	9.23e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—PLAU—breast cancer	1.4e-05	9.23e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—FGF3—breast cancer	1.4e-05	9.21e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—GSTA1—breast cancer	1.4e-05	9.18e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—IDH1—breast cancer	1.4e-05	9.18e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—ABCG2—breast cancer	1.39e-05	9.15e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—MTR—breast cancer	1.39e-05	9.15e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—CPT1A—breast cancer	1.39e-05	9.15e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—NQO1—breast cancer	1.38e-05	9.11e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—SLC2A1—breast cancer	1.38e-05	9.11e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—JAG1—breast cancer	1.38e-05	9.09e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—FASN—breast cancer	1.38e-05	9.09e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—NAT2—breast cancer	1.38e-05	9.08e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—PARP1—breast cancer	1.38e-05	9.05e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—CAV1—breast cancer	1.37e-05	9.02e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet activation, signaling and aggregation—MAPK3—breast cancer	1.37e-05	9.01e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—HPGDS—breast cancer	1.36e-05	8.97e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—CALCA—breast cancer	1.36e-05	8.94e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	1.36e-05	8.92e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—HBA1—breast cancer	1.36e-05	8.92e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—CYP3A4—breast cancer	1.35e-05	8.88e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	1.34e-05	8.84e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—RPS6—breast cancer	1.34e-05	8.84e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—FGF4—breast cancer	1.33e-05	8.77e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet activation, signaling and aggregation—TGFB1—breast cancer	1.33e-05	8.75e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—CYP1B1—breast cancer	1.33e-05	8.73e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—CXCR4—breast cancer	1.33e-05	8.73e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—GSTT1—breast cancer	1.32e-05	8.7e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—ACHE—breast cancer	1.32e-05	8.7e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—SLC2A1—breast cancer	1.31e-05	8.64e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—FN1—breast cancer	1.3e-05	8.58e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—HSP90AA1—breast cancer	1.3e-05	8.57e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—NOS2—breast cancer	1.29e-05	8.48e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—breast cancer	1.28e-05	8.45e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—TCF7L2—breast cancer	1.28e-05	8.42e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—NCOA1—breast cancer	1.27e-05	8.33e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—CYP17A1—breast cancer	1.25e-05	8.24e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—PIK3CG—breast cancer	1.25e-05	8.21e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—STK11—breast cancer	1.25e-05	8.21e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—CYP19A1—breast cancer	1.25e-05	8.21e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—CAV1—breast cancer	1.25e-05	8.21e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—ENO1—breast cancer	1.24e-05	8.15e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—PTGS1—breast cancer	1.24e-05	8.15e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	1.23e-05	8.12e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—HSP90AA1—breast cancer	1.23e-05	8.12e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—EGF—breast cancer	1.23e-05	8.12e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—ALB—breast cancer	1.22e-05	8.02e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—CYP2D6—breast cancer	1.22e-05	8e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—MED12—breast cancer	1.21e-05	7.96e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—DPYD—breast cancer	1.21e-05	7.96e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—PRL—breast cancer	1.2e-05	7.9e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—NCOA2—breast cancer	1.19e-05	7.85e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—ALDOA—breast cancer	1.19e-05	7.84e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—ADAM10—breast cancer	1.18e-05	7.78e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism of lipids and lipoproteins—PTEN—breast cancer	1.17e-05	7.71e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—COMT—breast cancer	1.16e-05	7.63e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—FASN—breast cancer	1.16e-05	7.61e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—NCOA3—breast cancer	1.16e-05	7.61e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—GSTP1—breast cancer	1.15e-05	7.6e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—BCHE—breast cancer	1.15e-05	7.58e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—FGF10—breast cancer	1.15e-05	7.57e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—SLC2A2—breast cancer	1.15e-05	7.56e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—IGF1—breast cancer	1.14e-05	7.52e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—AKT2—breast cancer	1.14e-05	7.51e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—HMOX1—breast cancer	1.14e-05	7.49e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—SLC5A5—breast cancer	1.14e-05	7.49e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	1.14e-05	7.48e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—ITPR1—breast cancer	1.14e-05	7.48e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet activation, signaling and aggregation—PIK3CA—breast cancer	1.13e-05	7.44e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—MTR—breast cancer	1.13e-05	7.4e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—ABCG2—breast cancer	1.13e-05	7.4e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—CPT1A—breast cancer	1.13e-05	7.4e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—PDGFA—breast cancer	1.11e-05	7.31e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—HPGDS—breast cancer	1.1e-05	7.26e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—SLC2A1—breast cancer	1.1e-05	7.23e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—NQO1—breast cancer	1.1e-05	7.23e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—PIK3CD—breast cancer	1.1e-05	7.22e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—HBA1—breast cancer	1.1e-05	7.21e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—TGFBR2—breast cancer	1.09e-05	7.2e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—ABCB1—breast cancer	1.09e-05	7.19e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—SERPINE1—breast cancer	1.09e-05	7.14e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—ITPR1—breast cancer	1.08e-05	7.09e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	1.08e-05	7.08e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—TYMS—breast cancer	1.07e-05	7.06e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—CYP3A4—breast cancer	1.07e-05	7.05e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—GSTT1—breast cancer	1.07e-05	7.04e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—ACHE—breast cancer	1.07e-05	7.04e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—STAT5A—breast cancer	1.07e-05	7.04e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—ERBB4—breast cancer	1.07e-05	7.04e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—GSTM1—breast cancer	1.06e-05	6.98e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—PLA2G4A—breast cancer	1.06e-05	6.98e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—NCOR1—breast cancer	1.06e-05	6.98e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—CYP1B1—breast cancer	1.05e-05	6.93e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—SMAD4—breast cancer	1.04e-05	6.82e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—NOS3—breast cancer	1.04e-05	6.82e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—HSP90AA1—breast cancer	1.03e-05	6.8e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—GPX1—breast cancer	1.02e-05	6.69e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—CYP17A1—breast cancer	1.01e-05	6.66e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—HES1—breast cancer	1.01e-05	6.66e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—CYP1A1—breast cancer	1.01e-05	6.62e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—NCOR1—breast cancer	1.01e-05	6.62e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—NCOA1—breast cancer	1.01e-05	6.61e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—ENO1—breast cancer	1e-05	6.6e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—PTGS1—breast cancer	1e-05	6.6e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	9.99e-06	6.57e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—ERCC2—breast cancer	9.98e-06	6.57e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—FGF1—breast cancer	9.95e-06	6.54e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—CYP19A1—breast cancer	9.91e-06	6.52e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—STK11—breast cancer	9.91e-06	6.52e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—NRG1—breast cancer	9.88e-06	6.5e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—CYP2D6—breast cancer	9.83e-06	6.47e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—H2AFX—breast cancer	9.8e-06	6.45e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—RAF1—breast cancer	9.8e-06	6.45e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—NCOA2—breast cancer	9.65e-06	6.35e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—PIK3CB—breast cancer	9.57e-06	6.29e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—ERCC2—breast cancer	9.46e-06	6.22e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—MTHFR—breast cancer	9.38e-06	6.17e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—FASN—breast cancer	9.36e-06	6.16e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—BCHE—breast cancer	9.32e-06	6.13e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—PTEN—breast cancer	9.3e-06	6.12e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—ERBB3—breast cancer	9.25e-06	6.09e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet activation, signaling and aggregation—AKT1—breast cancer	9.24e-06	6.08e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—FGFR2—breast cancer	9.24e-06	6.08e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—COMT—breast cancer	9.21e-06	6.06e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—SLC5A5—breast cancer	9.21e-06	6.06e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—GSTP1—breast cancer	9.17e-06	6.03e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—HMOX1—breast cancer	9.04e-06	5.95e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—ITPR1—breast cancer	9.02e-06	5.94e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—NQO1—breast cancer	8.89e-06	5.85e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—SLC2A1—breast cancer	8.89e-06	5.85e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—MTHFR—breast cancer	8.89e-06	5.85e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—TERT—breast cancer	8.87e-06	5.83e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—IL2—breast cancer	8.79e-06	5.78e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	8.71e-06	5.73e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—ABCB1—breast cancer	8.68e-06	5.71e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—CYP3A4—breast cancer	8.67e-06	5.71e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—CAV1—breast cancer	8.65e-06	5.69e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	8.63e-06	5.68e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—FGFR1—breast cancer	8.61e-06	5.66e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—CYP1B1—breast cancer	8.53e-06	5.61e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—TYMS—breast cancer	8.52e-06	5.61e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Transmembrane transport of small molecules—RAF1—breast cancer	8.48e-06	5.58e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—HIF1A—breast cancer	8.48e-06	5.58e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—PLA2G4A—breast cancer	8.43e-06	5.54e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—GSTM1—breast cancer	8.43e-06	5.54e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—NCOR1—breast cancer	8.43e-06	5.54e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—HSP90AA1—breast cancer	8.36e-06	5.5e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	8.27e-06	5.44e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—CAV1—breast cancer	8.2e-06	5.4e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—NCOA1—breast cancer	8.13e-06	5.35e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—GPX1—breast cancer	8.07e-06	5.31e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—CYP19A1—breast cancer	8.02e-06	5.27e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—STK11—breast cancer	8.02e-06	5.27e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—CYP1A1—breast cancer	7.99e-06	5.25e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—ERCC2—breast cancer	7.92e-06	5.21e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—PIK3CG—breast cancer	7.88e-06	5.18e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—NOS2—breast cancer	7.71e-06	5.07e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—SRC—breast cancer	7.67e-06	5.04e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—NOTCH1—breast cancer	7.64e-06	5.03e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—PTEN—breast cancer	7.53e-06	4.95e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—APC—breast cancer	7.47e-06	4.91e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—KIT—breast cancer	7.47e-06	4.91e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—VEGFA—breast cancer	7.47e-06	4.91e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—COMT—breast cancer	7.45e-06	4.9e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—MTHFR—breast cancer	7.45e-06	4.9e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—GSTP1—breast cancer	7.42e-06	4.88e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—EGF—breast cancer	7.38e-06	4.86e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—HMOX1—breast cancer	7.32e-06	4.81e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—ITPR1—breast cancer	7.3e-06	4.8e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—MAPK3—breast cancer	7.06e-06	4.65e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—BRAF—breast cancer	7.02e-06	4.62e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—ABCB1—breast cancer	7.02e-06	4.62e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—PIK3CD—breast cancer	6.93e-06	4.56e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—TYMS—breast cancer	6.9e-06	4.54e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—CAV1—breast cancer	6.87e-06	4.52e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—TGFB1—breast cancer	6.85e-06	4.51e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—ALB—breast cancer	6.84e-06	4.5e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—AKT2—breast cancer	6.84e-06	4.5e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—NCOR1—breast cancer	6.82e-06	4.48e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—GSTM1—breast cancer	6.82e-06	4.48e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—PLA2G4A—breast cancer	6.82e-06	4.48e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—PIK3CD—breast cancer	6.57e-06	4.32e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	6.56e-06	4.32e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—NOS3—breast cancer	6.54e-06	4.3e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—GPX1—breast cancer	6.53e-06	4.29e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—SERPINE1—breast cancer	6.5e-06	4.27e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—CYP1A1—breast cancer	6.46e-06	4.25e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—ERCC2—breast cancer	6.41e-06	4.22e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—KRAS—breast cancer	6.35e-06	4.18e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—PIK3CG—breast cancer	6.26e-06	4.12e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—NOS3—breast cancer	6.2e-06	4.08e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—PIK3CB—breast cancer	6.04e-06	3.97e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—MTHFR—breast cancer	6.02e-06	3.96e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—PTGS2—breast cancer	5.98e-06	3.94e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—MDM2—breast cancer	5.88e-06	3.87e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—RAF1—breast cancer	5.86e-06	3.86e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—PIK3CA—breast cancer	5.83e-06	3.84e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—ERBB2—breast cancer	5.8e-06	3.82e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—PIK3CB—breast cancer	5.72e-06	3.77e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—MTOR—breast cancer	5.72e-06	3.77e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—CD4—breast cancer	5.71e-06	3.76e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—TP53—breast cancer	5.64e-06	3.71e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—CAV1—breast cancer	5.56e-06	3.66e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—PIK3CD—breast cancer	5.5e-06	3.62e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—ALB—breast cancer	5.43e-06	3.57e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—HRAS—breast cancer	5.4e-06	3.55e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—CDKN1B—breast cancer	5.37e-06	3.53e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	5.31e-06	3.49e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—PTEN—breast cancer	5.22e-06	3.43e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—NOS3—breast cancer	5.19e-06	3.42e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—CTNNB1—breast cancer	5.08e-06	3.34e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—PIK3CG—breast cancer	5.06e-06	3.33e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—CDKN1A—breast cancer	4.96e-06	3.26e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—PTEN—breast cancer	4.95e-06	3.25e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—PIK3CB—breast cancer	4.79e-06	3.15e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—AKT1—breast cancer	4.76e-06	3.13e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—SRC—breast cancer	4.59e-06	3.02e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—PIK3CD—breast cancer	4.45e-06	2.93e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—STAT3—breast cancer	4.42e-06	2.91e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—MAPK3—breast cancer	4.23e-06	2.78e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—NOS3—breast cancer	4.2e-06	2.76e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—PTEN—breast cancer	4.14e-06	2.73e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—MYC—breast cancer	4.11e-06	2.7e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—TGFB1—breast cancer	4.1e-06	2.7e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—EGFR—breast cancer	4.02e-06	2.65e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—PIK3CB—breast cancer	3.88e-06	2.55e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—PTGS2—breast cancer	3.84e-06	2.53e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—KRAS—breast cancer	3.8e-06	2.5e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—PIK3CA—breast cancer	3.68e-06	2.42e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—PIK3CA—breast cancer	3.49e-06	2.3e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—PTEN—breast cancer	3.35e-06	2.2e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—HRAS—breast cancer	3.23e-06	2.12e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—IL6—breast cancer	3.09e-06	2.03e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—AKT1—breast cancer	3.01e-06	1.98e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—PIK3CA—breast cancer	2.92e-06	1.92e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—AKT1—breast cancer	2.85e-06	1.88e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—AKT1—breast cancer	2.39e-06	1.57e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—PIK3CA—breast cancer	2.36e-06	1.56e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—AKT1—breast cancer	1.93e-06	1.27e-05	CbGpPWpGaD
